Skip to content

Role of preoperative echocardiography for prevention of cardiovascular event after non-cardiac surgery; Prospective randomized-controlled trial for intermediate risk patients

Role of pre-operative echocardiography for the prevention of cardiovascular accident after non-cardiac surgery (PREOP-ECHO Trial)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006279
Enrollment
2330
Registered
2021-06-21
Start date
2021-05-26
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Echocardiography ) : In ECHO group, the echocardiography according to the standard protocol is performed before the previously scheduled non-cardiovascular surgery, and according to the results

Sponsors

Yonsei University Health System, Gangnam Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A patient expected to undergo intermediate-risk non-cardiovascular surgery according to the ESC/AHA guidelines and have two or less clinical cardiovascular risk factors from the revised cardiac risk index. 2. A patient without compelling indication for the echocardiography.

Exclusion criteria

Exclusion criteria: 1. A patient undergoing low-risk or high-risk non-cardiovascular surgery according to the ESC/AHA guidelines. 2. A patient who conducted echocardiography within 3 months from the time of study registration 3. A patient whose life expectancy is less than 6 months. 4. A patient undergoing emergency surgery. 5. Functional capacity < 4 METs

Design outcomes

Primary

MeasureTime frame
A composite of all-cause death, aborted sudden cardiac arrest, type I myocardial infarction, clinically diagnosed unstable angina, stress-induced cardiomyopathy, lethal arrhythmia such as sustained ventricular tachycardia or ventricular fibrillation, newly diagnosed or acutely decompensated heart failure.

Secondary

MeasureTime frame
A composite of cerebrovascular attack, transient ischemic attack, systemic embolization, pulmonary thromboembolism, type II myocardial infarction, non-lethal arrhythmia such as non-sustained ventricular tachycardia or atrial fibrillation, and change of NT-proBNP.;cases in which cardiac interventions are necessary before surgery or significant cardiac disease are newly detected.

Countries

Korea, Republic of

Contacts

Public ContactEun Kyoung Kim

Samsung Medical Center

ekbobi.kim@samsung.com+82-2-3410-3419

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 13, 2026